Česká spořitelna, a Sample Clauses

Česká spořitelna, a s., with its registered office at Prague 4, Xxxxxxxxxxx 0000/00, Xxxxxx Xxxx 000 00, Identification No. 452 44 782, registered in the Commercial Register maintained by the Municipal Court in Prague, Section B, Insert 1171 as fiscal and paying agent (in this capacity the Fiscal and Paying Agent)
AutoNDA by SimpleDocs
Česká spořitelna, a s., a joint-stock company and a bank incorporated under the laws of the Czech Republic, with its registered office at Xxxxxxxxxxx 0000/00, 000 00 Xxxxxx 0, Identification Number: 452 44 782, registered in the Commercial Register maintained by the Municipal Court in Prague, File Number: B 1171 (CS and in its capacity as listing agent, the Listing Agent);
Česká spořitelna, a s. With its registered office at: Xxxxxx 0, Xxxxxxxxxxx 0000/00, Post Code: 14000 Entered in: The Commercial Register maintained by the Municipal Court in Prague, File No. B 1171 Acting by: _________________________________________ ID No.: 00000000 Banking details: _________________________________________ (“Client”)
Česká spořitelna, a. S. as Koruna Paying Agent (the Koruna Paying Agent). IT IS AGREED as follows:

Related to Česká spořitelna, a

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

Time is Money Join Law Insider Premium to draft better contracts faster.